NCT06586697View on ClinicalTrials.gov

First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy

PHASE2RecruitingINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

March 20, 2026

Conditions

Extensive-stage Small-cell Lung Cancer

Interventions

RADIATION

Thoracic Radiotherapy

Thoracic Radiotherapy (45Gy /1.5Gy/bid/3w)

Trial Locations (1)

450000

RECRUITING

HenanCH, Zhengzhou

All Listed Sponsors

lead

Henan Cancer Hospital

OTHER_GOV